Authors: FISHER A BRANDEIS R HARING R ESHHAR N HELDMAN E KARTON Y EISENBERG O MESHULAM H MARCIANO D BARNER N PITTEL Z

Citation: A. Fisher et al., NOVEL M1 MUSCARINIC AGONISTS IN TREATMENT AND DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE - AN UNIFYING HYPOTHESIS, J PHYSL-PAR, 92(5-6), 1998, pp. 337-340

Authors: FISHER A HARING R GINZBURG I SADOT E PITTEL Z BARG Y BEHAR L GURWITZ D KARTON Y MESHULAM H MARCIANO D BRANDEIS R HELDMAN E

Citation: A. Fisher et al., NOVEL M1 AGONISTS - FROM SYMPTOMATIC TREATMENT TO DELAYING THE PROGRESSION OF ALZHEIMERS-DISEASE (AD), Journal of neurochemistry, 66, 1996, pp. 9-9

Authors: GURWITZ D HARING R PINKASKRAMARSKI R STEIN R HELDMAN E KARTON Y FISHER A

Citation: D. Gurwitz et al., NGF-DEPENDENT NEUROTROPHIC-LIKE EFFECTS OF AF102B, AN M1 MUSCARINIC AGONIST, IN PC12M1 CELLS, NeuroReport, 6(3), 1995, pp. 485-488

Authors: HARING R GURWITZ D BARG J PINKASKRAMARSKI R HELDMAN E PITTEL Z DANENBERG HD WENGIER A MESHULAM H MARCIANO D KARTON Y FISHER A

Citation: R. Haring et al., NGF PROMOTES AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTOR ACTIVATION, Biochemical and biophysical research communications, 213(1), 1995, pp. 15-23

Authors: HARING R GURWITZ D BARG J PINKASKRAMARSKI R HELDMAN E PITTEL Z WENGIER A MESHULAM H MARCIANO D KARTON Y FISHER A

Citation: R. Haring et al., AMYLOID PRECURSOR PROTEIN SECRETION VIA MUSCARINIC RECEPTORS - REDUCED DESENSITIZATION USING THE M1-SELECTIVE AGONIST AF102B, Biochemical and biophysical research communications, 203(1), 1994, pp. 652-658

Authors: JACOBSON KA GALLORODRIGUEZ C MELMAN N FISCHER B MAILLARD M VANBERGEN A VANGALEN PJM KARTON Y

Citation: Ka. Jacobson et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF 8-STYRYLXANTHINES AS A(2)-SELECTIVE ADENOSINE ANTAGONISTS, Journal of medicinal chemistry, 36(10), 1993, pp. 1333-1342